Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
11.33
-0.10 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
11.80
4.15%
After-hours: Aug 15, 2025, 06:53 PM EDT
Cartesian Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 15.89M | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M | -9M | -11.39M | -21.66M | 5.89M | -7.89M | 8.6M | 28.78M | 12.24M | -17.89M | 4.57M | -24.6M |
Depreciation & Amortization | 589K | 1.16M | 486K | 300K | 196K | 183K | 272K | 189K | 176K | 206K | 607K | 539K | 498K | 644K | 323K | 622K | 582K | 479K |
Stock-Based Compensation | 3.28M | 2.51M | 1.86M | 1.7M | 1.59M | 1.43M | 14.14M | 2.32M | 3.78M | 2.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 8.01M | -8.01M | 2.15M | -1.49M | -1.29M | -10.21M | -2.27M | -976K | -654K | 9.16M | -4.31M | -14.41M | -13.36M | -28.54M | -33.92M | -13.41M | -7.81M | -5.98M |
Other Non-Cash Items | -44.36M | -1.98M | -5.95M | 10.07M | 2.01M | 45.66M | 18.78M | 358K | 561K | 814K | -7.36M | -6.32M | 26.11M | -17.02M | -1.54M | 193K | -1.09M | 20.85M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 125.09M | -3.05M | -6.34M | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 7.08M | -7.08M | 6.85M | 25.81M | -32.08M | -6.37M | -3.91M | -34K | 3.31M | 5.6M | -7.04M | 2.35M | -29.92M | -25.76M | -37.88M | 5M | -8.37M | -6.94M |
Operating Cash Flow | -17.52M | -23.11M | -7M | 13.69M | -14.45M | -15.92M | -23.29M | -9.21M | -9.89M | -8.77M | -11.85M | 4.35M | -12.27M | -11.86M | -31.46M | -10.75M | -6.04M | -12.13M |
Capital Expenditures | -2.6M | -1.07M | -705K | -6.2M | -1.59M | -602K | -64K | n/a | -12K | -130K | -211K | -436K | -99K | -455K | -278K | -164K | -618K | -25K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 6.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -33.5M | n/a | n/a | n/a | -8.04M | -2M | -22.42M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.25M | 5.7M | 4M | n/a | 10M | 10M | 6.4M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 351K | n/a | n/a | n/a | 6.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.6M | -1.07M | -354K | -6.2M | -1.59M | -602K | 6.5M | n/a | -12K | 28.12M | 5.49M | -29.94M | -99K | 9.54M | 9.72M | -1.8M | -2.62M | -22.45M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 60K | -8.03M | 783K | 124.49M | 120K | 3.03M | 20.25M | n/a | -2.59M | 149K | 110K | 197K | n/a | 38K | 104K | 91K | 428K | 316K |
Financial Cash Flow | 60K | -8.03M | 783K | 124.49M | 120K | 43.03M | 14.08M | -24.79M | -2.59M | 149K | n/a | 612K | 36.88M | 1.73M | 21.16M | 1.45M | 8.98M | 21.31M |
Net Cash Flow | -20.04M | -32.18M | -6.59M | 131.97M | -15.9M | 26.51M | -2.69M | -34.02M | -12.52M | 19.49M | -6.12M | -25.21M | 24.62M | -620K | -588K | -11.1M | 326K | -13.27M |
Free Cash Flow | -20.12M | -24.18M | -7.71M | 7.49M | -16.03M | -16.52M | -23.35M | -9.21M | -9.91M | -8.89M | -12.06M | 3.92M | -12.37M | -12.32M | -31.74M | -10.91M | -6.66M | -12.16M |